E UROPEAN CURRICULUM VITAE · 2020. 12. 11. · Page 1 - Curriculum vitae of Giorgio Iervasi...

16
Page 1 - Curriculum vitae of Giorgio Iervasi [email protected] E UROPEAN CURRICULUM VITAE PERSONAL INFORMATION Name GIORGIO IERVASI Address BORGO SAN IACOPO, 175 LIVORNO Telephone +39 050 3152017 Fax +39 050 3152651 E-mail [email protected]; [email protected] Nationality ITALIAN Date of birth LIVORNO, 30/05/1954 WORKING EXPERIENCE • Dates 2019-present • Name and address of employer National Research Council, Institute of Clinical Physiology – Pisa, Italy • Type of business or sector Management of relationships between CNR and local and regional and public and private Institutions • Occupation or position held President of CNR Research Campus of Pisa • Main activities and responsibilities Coordinations of activities of CNR Institutes of Pisa • Dates 2014-present • Name and address of employer National Research Council, Institute of Clinical Physiology – Pisa, Italy • Type of business or sector Scientific Research • Occupation or position held Director, Institute of Clinical Physiology, National Council Research (C.N.R.) • Main activities and responsibilities Responsible for all the research activities of the Institute of Clinical Physiology-CNR • Dates 2015-present • Name and address of employer Scuola Superiore Sant’Anna Pisa, Italy • Type of business or sector Translational Medicine • Occupation or position held Member of Faculty of Translational Medicine PhD • Main activities and responsibilities Teaching activities in Cardiovascular Endocrine Translational Medicine • Dates 2014 • Name and address of employer “Summer School” University of Pisa, Pisa, Italy • Type of business or sector Cardiovascular Pathophysiology • Occupation or position held Professor • Main activities and responsibilities Teaching activities in Cardiovascular Endocrinology Pathophysiology • Dates 2012-2014 • Name and address of employer CNR-Tuscany Region G. Monasterio Foundation, Pisa, Italy • Type of business or sector Cardiovascular Endocrinology and Metabolism • Occupation or position held Scientific Coordinator of CNR-Tuscany Region G. Monasterio Foundation • Main activities and responsibilities Coordinator of all scientific activities

Transcript of E UROPEAN CURRICULUM VITAE · 2020. 12. 11. · Page 1 - Curriculum vitae of Giorgio Iervasi...

  • Page 1 - Curriculum vitae of Giorgio Iervasi [email protected]

    E U R O P E A N

    C U R R I C U L U M V I T A E

    PERSONALINFORMATION

    Name GIORGIOIERVASI

    Address BORGOSANIACOPO,175LIVORNO

    Telephone +390503152017

    Fax +390503152651E-mail [email protected];[email protected]

    Nationality ITALIANDateofbirth LIVORNO,30/05/1954

    WORKINGEXPERIENCE

    •Dates 2019-present

    •Nameandaddressofemployer NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy•Typeofbusinessorsector ManagementofrelationshipsbetweenCNRandlocalandregionalandpublicandprivateInstitutions

    •Occupationorpositionheld PresidentofCNRResearchCampusofPisa•Mainactivitiesandresponsibilities CoordinationsofactivitiesofCNRInstitutesofPisa

    •Dates 2014-present

    •Nameandaddressofemployer NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy•Typeofbusinessorsector ScientificResearch•Occupationorpositionheld Director,InstituteofClinicalPhysiology,NationalCouncilResearch(C.N.R.)

    •Mainactivitiesandresponsibilities ResponsibleforalltheresearchactivitiesoftheInstituteofClinicalPhysiology-CNR

    •Dates 2015-present

    •Nameandaddressofemployer ScuolaSuperioreSant’AnnaPisa,Italy•Typeofbusinessorsector TranslationalMedicine•Occupationorpositionheld MemberofFacultyofTranslationalMedicinePhD

    •Mainactivitiesandresponsibilities TeachingactivitiesinCardiovascularEndocrineTranslationalMedicine

    •Dates 2014•Nameandaddressofemployer “SummerSchool”UniversityofPisa,Pisa,Italy

    •Typeofbusinessorsector CardiovascularPathophysiology•Occupationorpositionheld Professor

    •Mainactivitiesandresponsibilities TeachingactivitiesinCardiovascularEndocrinologyPathophysiology

    •Dates 2012-2014•Nameandaddressofemployer CNR-TuscanyRegionG.MonasterioFoundation,Pisa,Italy

    •Typeofbusinessorsector CardiovascularEndocrinologyandMetabolism•Occupationorpositionheld ScientificCoordinatorofCNR-TuscanyRegionG.MonasterioFoundation

    •Mainactivitiesandresponsibilities Coordinatorofallscientificactivities

  • Page 2 - Curriculum vitae of Giorgio Iervasi [email protected]

    •Dates 2012-2014•Nameandaddressofemployer “ScientificAssociate”oftheEuropeanfoundedProjectFP7-ICT-2011-8"BioASQ”Achallengeonlarge-

    scalebiomedicalsemanticindexingandquestionanswering•Typeofbusinessorsector ScientificResearch

    •Occupationorpositionheld “ScientificAssociate”•Mainactivitiesandresponsibilities ParticipationtothedevelopmentofanewBiomedicalWeb-basedplatform

    •Dates 2012-present

    •Nameandaddressofemployer NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy./TuscanyRegionGMonasterioFoundation-Pisa,Italy

    •Typeofbusinessorsector Thyroiddysfunctionandcardiovascularrisk•Occupationorpositionheld MemberoftheSteeringCommitteeof“ThyroidStudiesCollaborationGroup”

    •Mainactivitiesandresponsibilities The international scientific association includes theworldwide recognized experts on relationshipsbetweenthyroiddysfunctionandcardiovascularrisk

    •Dates 2011-2013

    •Nameandaddressofemployer NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy/TuscanyRegionGMonasterioFoundation-Pisa,Italy

    •Typeofbusinessorsector CardiovascularEndocrinologyandMetabolismClinical•Occupationorpositionheld Head of Cardiovascular Endocrinology and Metabolism Clinical & Experimental Department

    C.N.R./TuscanyRegionGMonasterioFoundation•Mainactivitiesandresponsibilities Responsible for the clinical and scientific activities of Endocrinology and Metabolism Clinical &

    ExperimentalDepartmentC.N.R./TuscanyRegionGMonasterioFoundation

    •Dates 2011-present•Nameandaddressofemployer MinistryofHealthandNationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy

    •Typeofbusinessorsector ScientificResearch•Occupationorpositionheld Member

    •Mainactivitiesandresponsibilities Program Committee Member of the ‘Procollo Intesa’ between the Ministry of Health and CNR:integrationoftheHealthMinistryandCNRinitiatives

    •Dates 2009-2014

    •Nameandaddressofemployer ScuolaSuperioreS.AnnaPisa,Italy•Typeofbusinessorsector CardiovascularEndocrinologyandMetabolism

    •Occupationorpositionheld InvitedProfessorattheScuolaSuperioreS.Anna•Mainactivitiesandresponsibilities TeachingactivitiesinCardiovascularEndocrinologyandMetabolism

    •Dates 2007-2013

    •Nameandaddressofemployer NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy.•Typeofbusinessorsector CardiovascularEndocrinologyandMetabolism•Occupationorpositionheld ResearchDirector,C.N.R.InstituteofClinicalPhysiology

    •Mainactivitiesandresponsibilities Coordinatorofresearchactivities

    •Dates 2006•Nameandaddressofemployer “Higher Education Commission International Center for Chemical and Biological Sciences ” (HEJ),

    ResearchInstituteofChemistry,Karachi,Pakistan•Typeofbusinessorsector ChemicalandBiologicalSciences•Occupationorpositionheld InvitedProfessor

    •Mainactivitiesandresponsibilities 6“On–lineLectures”(LecturesthroughVideoConferencing).

    •Dates 2004•Nameandaddressofemployer NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy

    •Typeofbusinessorsector Endocrinology•Occupationorpositionheld Invitedmemberto“TreatmentofHypothyroidism:ALookAhead”CytomelAdvisoryBoardMeeting-

    WashingtonDC–USA(Othermembers:Dr.I.Kein,NewYork,Dr.J.R.Garber,Boston,Dr.D.Ascheim,New York, Dr. T. Bigos, Scarborough, Dr. P.W. Clyde, Virginia Beach, Dr. S. Danzi, Manhasset, Dr. J.Klemperer,Bangor,Dr.R.Levine,Nashua,Dr.S.J.Mendel,Ardmore)

    •Mainactivitiesandresponsibilities Expertscientificconsultant

    •Dates 2003•Nameandaddressofemployer AmericanAssociationforEradicationofHeartAttack–VulnerablePlaque(AEHA)

    •Occupationorpositionheld InvitedmemberoftheScientificAdvisoryBoard•Mainactivitiesandresponsibilities Editorialactivities

  • Page 3 - Curriculum vitae of Giorgio Iervasi [email protected]

    •Dates 2001-2006•Nameandaddressofemployer NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy

    •Typeofbusinessorsector CardiovascularEndocrinologyandMetabolism•Occupationorpositionheld SeniorResearcherC.N.R.,InstituteofClinicalPhysiology

    •Mainactivitiesandresponsibilities Responsibleofresearchprojects

    •Dates 1998-2010•Nameandaddressofemployer NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy

    •Typeofbusinessorsector CardiovascularEndocrinologyandMetabolism•Occupationorpositionheld Chief of the Cardiovascular Endocrine Research and Clinical Unit of the C.N.R. Institute of Clinical

    Physiology/G.MonasterioFoundation•Mainactivitiesandresponsibilities Clinicalandresearchactivities

    •Dates 1998-2004

    •Nameandaddressofemployer ScuolaSuperioreS.AnnaPisa,Italy,incollaborationwithIFC-CNRandtheInternationalHeartSchool,BergamoItaly

    •Typeofbusinessorsector “InternationalMasterinCardiology,Cardio-surgeryandcorrelatedAnesthesia”•Occupationorpositionheld Professor

    •Mainactivitiesandresponsibilities Professorwithintheframeofthevariouseditionsofthe“InternationalMasterinCardiology,Cardio-surgeryandcorrelatedAnesthesia”

    •Dates 1997-2000

    •Nameandaddressofemployer MinistryofEducation,UniversitiesandResearch(Italy)•Typeofbusinessorsector CardiovascularEndocrinologyandMetabolism

    •Occupationorpositionheld Responsible•Mainactivitiesandresponsibilities ResponsibleofWorkPackage2,CCCN1"Biologicalandmolecularbasesofcongenitalneonatalheart

    diseases,neuroendocrinefactorsandcardiomyocytes:analysis, identificationandcharacterizationofpossiblecorrelationsbetweencongenitalheartdiseasesandsystemicandintracellularmetabolismofthyroidhormones"oftheNationalProject"NeonatalcriticalcongenitalHeartDisease."

    •Dates 1991-1997

    •Nameandaddressofemployer UniversityofPisa,Italy•Typeofbusinessorsector InternalMedicineandNuclearMedicine•Occupationorpositionheld Invited Professor Post graduate Schools for Doctors (Internal Medicine and Nuclear Medicine

    Specialties)•Mainactivitiesandresponsibilities TeachingactivitiesinInternalMedicineandNuclearMedicine

    •Dates 1991-1994

    •Nameandaddressofemployer UniversityofPisa,Italy•Typeofbusinessorsector "Elements of Radiobiology, Radiation Dosimetry and Applied Biology of non-ionized andMetabolic

    StudieswithRadioactiveTracersinNuclearMedicine"•Occupationorpositionheld InvitedadjunctProfessor

    •Mainactivitiesandresponsibilities Teaching activities in Elements of Radiobiology, Radiation Dosimetry and Applied Biology of non-ionizedandMetabolicStudieswithRadioactiveTracersinNuclearMedicine

    •Dates 1991-1992

    •Nameandaddressofemployer UniversityofPisa,Italy•Typeofbusinessorsector “GastroenterologyandDigestiveEndoscopy”

    •Occupationorpositionheld InvitedadjunctProfessor•Mainactivitiesandresponsibilities TeachingactivitiesinNuclearMedicineGastroenterology

    •Dates 1990

    •Nameandaddressofemployer NationalResearchCouncil,InstituteofClinicalPhysiology–Pisa,Italy•Typeofbusinessorsector CardiovascularEndocrinologyandMetabolism

    •Occupationorpositionheld ResearcherC.N.R.,InstituteofClinicalPhysiology•Mainactivitiesandresponsibilities Researchactivities

    EDUCATIONANDTRAINING

    •Dates•Nameandtypeoforganisationprovidingeducationandtraining•Principalsubjects/occupational

    skillscovered

    June-December2015MIPPolitecnicodiMilanoGraduateSchoolofBusinessAdvancedCourse“ManagementpathforthedirectorsofscientificstructuresoftheCNR”-Directorofthecourse:ProfMArbaboldi

  • Page 4 - Curriculum vitae of Giorgio Iervasi [email protected]

    •Dates 1986

    •Nameandtypeoforganisationprovidingeducationandtraining

    UniversityofPisa,Pisa,Italy

    •Principalsubjects/occupationalskillscovered

    NuclearMedicine

    •Levelinnationalclassification Specialization

    •Dates 1983•Nameandtypeoforganisationprovidingeducationandtraining

    UniversityofPisa,Pisa,Italy

    •Principalsubjects/occupationalskillscovered

    InternalMedicine

    •Levelinnationalclassification Specialization

    •Dates 1978•Nameandtypeoforganisationprovidingeducationandtraining

    UniversityofPisa,Pisa,Italy

    •Principalsubjects/occupationalskillscovered

    Medicine

    •Titleofqualificationawarded GraduatedegreeinMedicine•Levelinnationalclassification MD

    MOTHERTONGUE

    Italian

    OTHERLANGUAGES English•Reading Intermediate•Writing Intermediate•Speaking Intermediate

    OTHERLANGUAGES French

    •Reading Basic•Writing Basic•Speaking Basic

    • OTHERRELEVANT

    INFORMATIONABOUTTHESCIENTIFICAND

    PROFESSIONALCAREER

    -MemberoftheSelectFacultytosubmitnominationfor2016RossPrizeMolecularMedicine.-PresidentofCNRExpertPanel(BiomedicalArea)fortheevaluationofresearchprojectsoftheItalianMinistryofEconomicDevelopment(MISE)-CNRCoordinatorofthe“CasaItalia”projectforthe“Exposuretoriskofpeopleandthings”.ManagementPathforDirectorsofScintificResearchDepartmentsofCNRNationalResearchCouncil–DirectorofCourseProf.MichelaArnaboldi–PolitecnicodiMilanoGraduateSchoolofBusiness–July/December2015InternationalexperienceEducation1998 Post-doctoral Course at the Albert Einstein College of Medicine and Montefiore Medical Center" New York, U.S.A. 1996 Holder of CNR extraordinary assignment, Central Scientific Activity Department, for a three-month study stay at the NIH (Bethesda, USA) Member:ManagingEditor:InternationalJournalofEndocrinologyEditorialBoard:FrontiersPhysiologyEditorialBoard:FrontiersEndocrinologyEditorialBoard:WorldJournalofDiabetesEditorialBoard:JournalofGeriatricCardiologyEditorialBoard:ISRNCardiology2009 EditoroftheBook“ThyroidandHeartFailureFromPathophysiologytoClinics”,SpringerVerlagPublisher.Reviewerfor:CirculationNatureReviewsEndocrinologyandMetabolismJournalofMolecularandCellularEndocrinology

  • Page 5 - Curriculum vitae of Giorgio Iervasi [email protected]

    JournalofClinicalEndocrinologyandMetabolismEndocrinologyAmericanJournalofPhysiologyEuropeanJournalofEndocrinologyCriticalCareClinicalEndocrinologyExperimentalPhysiologyAmericanJournalofCardiologyJournalofEndocrinologyEuropeanJournalofClinicalInvestigationThyroidMolecularandCellularEndocrinologyEndocrineEuropeanJournalofRadiologyRegulatoryPeptidesCriticalCareMedicineHormoneMetabolicResearchIntensiveCareMedicineBiochemistryandCellBiologyICRSCardiologyMedicalScienceMonitoring

    Maininternationalinvitedlectures(last10years):”XVI EUROPEAN CONGRESS OF ENDOCRINOLOGY; EUROPEAN SOCIETY OF ENDOCRINOLOGY” 3-7May2014,WROCLAWPoland;”Thyroiddysfunctionincriticallyillpatients:totreatornottotreat?“XV LATINAMERICANTHYROID CONGRESS”, 21-23March 2013, FLORIANOPOLIS, Brazil; “ThyroidHormonereplacementtherapyandheartfailure:whenandhow””XV LATIN AMERICAN THYROID CONGRESS”, 21-23 March 2013, FLORIANOPOLIS, Brazil;“ProangiogeneticactionofTSHthroughitsmembranereceptor””XV LATINAMERICANTHYROID CONGRESS”, 21-23March 2013, FLORIANOPOLIS, Brazil; “ThyroidHormoneandtheCardiovascularSystem:fromBasicConceptstoClinicalApplications”“CHINA HEART CONGRESS”, Beijing, China, 11-14 August 2011; ”Thyroid Hormone Treatment inCardiacDiseases:MoreLightthanShadow”“14THINTERNATIONALTHYROIDCONGRESS”,Paris,11-16September2010;“ThelowT3syndromeincardiacpatientsanditstreatmentwithT3”“INTERNATIONAL CARDIOLOGY CONGRESS: TRACK 1-15 2009: HEART FAILURE”, China; “Thyroidfunctionandheartfailure”

    Honors2003Awardas“FeaturedArticleoftheMonth"bytheAEHAInternationalSociety(AssociationfortheEradicationofHeartAttack)fortheArticle:"Low-T3Syndrome:astrongprognosticpredictorofdeathinpatientswithheartdisease"(Circulation2003;107:708-713)Maininternationalresearchsupport(last7years)-PartneroftheEuropeanCommunity-fundedSeventhFrameworkProgrammeThemeProjectCIP-ICT-PSP-2012, Title: “OpenScienceLink- Open Semantically-enabled, Social-aware Access to ScientificData”.Mainongoingnationalresearchsupport(last7years)-Responsible of three-year Italian Grant: “Study of the molecular, biochemical and metabolicmechanismsinvolvedinthecardioprotectiveeffectofT3”.

  • Page 6 - Curriculum vitae of Giorgio Iervasi [email protected]

    PUBBLICATIONS1. CarpiA.,IervasiG.,NicoliniA.,DelCorsoL.,LevantiC.,ZucchelliG.C.,BianchiR.Serumthyroidhormoneconcentrationsandrecovery

    ofTSHsecretionafterexcisionofautonomouslyfunctioningthyroidnodulesMetabolism1982;31(5):417-4202. Nicolini A., Immacolato M., Lazzerini G., Iervasi G., Carpi A. Effetti della associazione metimazomo-dibromotirosina sui livelli

    circolantidegliormonitiroideiedelTSHinPazientiipertiroideiFarmaci1983;4:3-83. CarpiA.,IervasiG.,NicoliniA.,BianchiR.ClinicaluseoffreeserumthyroidhormonesassaysRAYSSciences1984;9(1):131-1424. Bianchi R., Molea N., Cazzuola F., Fusani L., Iervasi G., Bertelli P., FerdeghiniM.,Mariani G. Separazione HPLC delle iodotironine

    siericheperstudisulmetabolismoperifericodegliormonitiroideiinvivo.LigandQuaterly1986:5(4):57-685. BianchiR.,PiloA.,IervasiG.,VitekF.,FerdeghiniM.,CazzuolaF.,MoleaN.MulticompartmentalvsnoncompartmentalanalysisofT4

    andT3kineticsinnormalsandhypothyroidpatients.NuklearmedizinF.K.SchattauerVerlag,1987,332-3346. Bianchi R., Iervasi G., Pilo A., Vitek F., Ferdeghini M., Cazzuola F., Giraudi G.F. Role of serum carrier proteins in the peripheral

    metabolismandtissuedistributionofthyroidhormonesinfamilialdysalbuminemichyperthyroxinemiaandcongenitalelevationofthyroxine-bindingglobulinJClinInvest1987;80:522-534

    7. Carpi A., Nicolini A., Iervasi G., Toscano S., Giannessi., Luti R. Evaluation of a new pharmacological preparation containing L-

    Thyroxineinsolution:comparisonwithL-ThyroxineandTriiodotironinetabletsClinicalTrialsJournal1988;25(3):172-1808. PiloA., IervasiG.,VitekF.,FerdeghiniM.,CazzuolaF.,BianchiR .Thyroidalandperipheralproductionof3,5,3’-triiodothyronine in

    humansbymulticompartmentalanalysisAmJPhysiol1990;258:E715-E7269. PiloA.,ZucchelliG.C.,MalvanoR.,ClericoA.,IervasiG.SignoriniC.Interassayvariabilityofimmunometricmethodsforthyrotropinin

    anexternalqualityassessmentsurvey:evidencethat functionalsensitivity isnotalwaysadequate forclinicaldecisionsClinChem1992;38:1345-9

    10. Bianchi R., Iervasi G., Matteucci F., Turchi S., Cazzuola F., Bellina R.C., Boni G., Molea N., Ferdeghini M., Toni M.G., Mariani G.

    Chromatographic identification in serum of endogenously radioiodinated thyroid hormones after iodine-131 whole bodyscintigraphyinthefollow-upofpatientswithdifferentiatedthyroidcarcinomaJNuclMed1993;34:2032-37

    11. Iervasi G. Clerico A., Berti S., Pilo A., Vitek F., Biagini A., BarattoM.T., Bianchi R., Donato L. ANP kinetics in normalmen: in vivo

    measurementbyatracermethodandcorrelationwithsodiumintake.AmJPhysiol1993;264:F480-912. PiloA.,IervasiG.,VitekF.,TurchiS.,BianchiR.DisposalanddistributionofrT3inhumans:anewdouble-tracerkineticstudyAmJ

    Physiol1993;264(2pt1):E239-4913. ClericoA.,IasconeM.R.,ManfrediC.andIervasiG.Theroleofnuclearmedicineintheassessmentoftheendocrinefunctionofthe

    heartJNuclBiolMed1994;38:37-4614. IervasiG.,ClericoA.,PiloA.,BertiS.,VitekF.,BiaginiA.,BianchiR.,DonatoL.Kineticstudyofatrialnatriureticpeptideinpatients

    with idiopathic dilated cardiomyopathy: evidence for resistance to biologic effects of the hormone even in patients with mildmyocardialinvolvementJCardiovascPharmacol1994;24:626-37

    15. BiaginiA.,IervasiG.,ClericoA.,BertiS.,PiloA.,VitekF.,BoniniR.,BianchiR.,DonatoL.Peripheralthyroidhormonemetabolismin

    patientswithcomplexventriculararrhythmiasAmJCardiol1995;75:630-316. ClericoA.,IervasiG.,BertiS.,PiloA.,VitekF.,SalvadoriS.,MarastoniM.,ManfrediC.,DelChiccaM.G.,IasconeM.R.,BiaginiA.Invivo

    measurementofANPoverallturnoverandidentificationotitsmainmetabolicpathwaysundersteadystateconditionsinhumansJEndocrinolInvest1995;18:194-204

    17. ClericoA.,IervasiG.,IasconeM.R.,ManfrediC.,SabatinoL.,BertelliA.,BertelliA.A.E.Evaluationoftheendocrinefunctionoftheheart

    inhumans:Proposalforanintegratedapproachfortheassessmentofproduction,secretion,distributionanddegradationofAtrialNatriureticFactorandRelatedPeptidesIntJClinPharmacol1995;15:65-86

    18. ClericoA.,IervasiG.,ManfrediC.,SalvadoriS.,MarastoniM.,TurchiS.,DelChiccaM.G.,GiannessiD.,DelRYS.,AndreassiM.G.,Biagini

    A.,DonatoL.Preparationofmono-radio-iodinatedtracersforstudyingtheinvivometabolismofatrialnatriureticpeptideinhumans.EurJNuclMed1995;22:997-1004

    19. ClericoA.,IervasiG.AlterationsinmetabolicclearanceofANPinheartfailure:howdoesitrelatetotheresitancetoANP?JCardFail

    1995;1(4):323-32820. IervasiG.,ClericoA.,BertiS.,PiloA.,BiaginiA.,BianchiR.,DonatoL.AlteredtissuedegradationanddistributionofAtrialNatriuretic

    Peptide in patients with idiopathic dilated cardiomyopathy and its relationshipwith clinical severity of the disease and sodiumhandlingCirculation1995;91:2018-27

    21. Manfredi C., Clerico A., Iervasi G., Turchi S., Cazzuola F., Berti S., Sabatino L., Biagini A. Measurement of serum amiodarone and

    desethylamiodaronebyHPLC:itsusefulnessinthefollow-upofarrhythmicpatientstreatedwithamiodaroneIntJClinPharmacol1995;15:87-93

    22. MurziB., IervasiG.,MasiniS.,MoschettiG.,VaniniV.,ZucchelliG.C.,BiaginiA.Thyroidhormoneshomeostasisinpediatricpatients

    duringandaftercardiopulmonaryby-passAnnThoracSurg1995;59:481-485

  • Page 7 - Curriculum vitae of Giorgio Iervasi [email protected]

    23. ClericoA.,IervasiG.,IasconeM.R.,ManfrediC.,SabatinoL.,BiaginiA.Resistancetobiologicaleffectsofatrialnatriureticpeptidein

    heartfailure.InternalMed1995;3:57-6424. Del Ry S., AndreassiM.G., Lazzerini G., Iervasi G., Clerico A., Biagini A., Giannessi D. Determination of endothelin binding sites in

    bovineatriumandventriclemembranes:amodelforbindingstudiesinhumancardiactissueIntJTissReac1995;XVII(3):117-12425. IervasiG.,ClericoA.,BertiS.,PiloA.,ManfrediC.,SabatinoL.,IasconeM.R.,PalmieriC.,BiaginiA.,DonatoL.Alteredperipheralthyroid

    hormonemetabolisminpatientswithcomplexventriculararrhythmiasandnormalserumconcentrationsofthyroidhormonesandTSHThyroidologyClinExp1995;7:43-8

    26. Iervasi G., Clerico A., Pilo A., Berti S., Vitek F., Biagini A., Bianchi R., Donato L. Normalization of peripheral thyroid hormone

    metabolism induced by successful chronic amiodarone treatment in patients with ventricular arrhythmias Eur J Clin Invest1996;26:382-90

    27. Berti S., Palmieri C., Ravani M., Bonini R., Iascone M.R., Clerico A., Manfredi C., Iervasi G., Biagini A. Acute enoximone effect on

    systemicandrenalhemodynamicsinpatientswithheartfailureCardiovascDrugTher1996;10:81-8728. Clerico A., Iervasi G., Del Chicca M.G., Maffei S., Berti S., Sabatino L., Turchi S., Cazzuola F., Manfredi C., Biagini A. Analytical

    performanceandclinicalusefulnessofacommerciallyavailable IRMAkit formeasuringatrialnatriureticpeptide inpatientswithheartfailureClinChem1996;42:1627-33

    29. IervasiG.,ClericoA.,BoniniR.,ManfrediC.,RavaniM.,ForiniF.,PalmieriC.,TurchiS.,CazzuolaF.,MusettiM.,BiaginiA.Acuteeffects

    of intravenous amiodarone administration on thyroid function in arrhythmic patients: preliminary results Thyroidol Clin Exp1996;8:21-27

    30. ClericoA., Iervasi G., Forini F. Importance of circulatorymodels in turnover studies of hormones rapidly cleared from the blood

    stream:theexampleofatrialnatriureticpeptideInternalMed1996;4:53-5631. Carpi A., Ferrari E., Sagripanti A., Nicolini A., Iervasi G., De Gaudio C., Romani R., Di Coscio G. Aspiration needle biopsy refines

    preoperativediagnosisofthyroidnodulesdefinesaspirationasmicrofollicularnoduleBiomedPharmacother1996;50(8):325-832. IervasiG.,ClericoA.,BoniniR.,ManfrediC.,BertiS.,RavaniM.,PalmieriC.,CarpiA.,BiaginiA.,ChopraI.J.Acuteeffectsofamiodarone

    administrationonthyroidfunctioninpatientswithcardiacarrhythmiaJClinEndocrinolMetab1997;82:275-8033. IervasiG.,ClericoA.,PiloA.,VitekF.,BertiS.,PalmieriC.,RavaniM.,SabatinoL.,ManfrediC.,DelChiccaM.G.,BiaginiA.,DonatoL.

    EvidencethatatrialnatriureticpeptidetissueextractionisnotchangedbylargeincreasesofitsplasmalevelsinducedbypacinginhumansJClinEndocrinolMetab1997;82:884-888

    34. IervasiG.,ClericoA.,ManfrediC.,SabatinoL.,BiaginiA.,ChopraI.J.Acuteeffectsofintravenousamiodaroneonsulphatemetabolites

    ofthyroidhormonesinarrhythmicpatientsClinEndocrinol1997;47(6):699-70535. PiloA., Iervasi G., ClericoA., Vitek F., Berti S., Palmieri A., Biagini A., Donato L. Circulatorymodel inmetabolic studies of rapidly

    renewedhormones:applicationtoANPkineticsAmJPhysiol(sez.“ModelinginPhysiology”)1998;274(3):E560-E57236. VitekF.,PiloA.,PichJ.,IervasiG.,ZitkoM.,ClericoA.Applicabilityofacirculatorymodelfordeterminingtheparametersofkineticsof

    endogenouslyproducedcompoundsSbornLek1998;99(4):539-54737. IervasiG.,ClericoA.,BoniniR.,NannipieriM.,ManfrediC., SabatinoL.,BiaginiA.,DonatoL.Effectofantiarrhythmic therapywith

    intravenous loading dose of amiodarone: evidence for an altered response in diabetic patients Int J Clin Pharmacol Res1998;18(3):109-20

    38. IervasiG.,ClericoA.,PiloA.,SabatinoL.,ManfrediC.,ForiniF.,DelChiccaM.G.,PalmieriC.,RavaniM.,DonatoL.Atrialnatriuretic

    peptideisnotdegradedbythelungsinhumansJClinEndocrinolMetab1998;83(8):2898-90639. Maffei S., ClericoA., IervasiG.,NannipieriM.,DelRy S., GiannessiD.,DonatoL. Circulating levels of cardiacnatriuretichormones

    measuredinwomenduringmenstrualcycleJEndocrinolInvest1999;22(1):1-540. ClericoA., IervasiG.,Del ChiccaM.G., EmdinM.,Maffei S.,NannipieriM., SabatinoL., Forini F.,ManfrediC.,DonatoL., Circulating

    levelsofcardiacnatriureticpeptides(ANPandBNP)measuredbyhighlysensitiveandspecificimmunoradiometricassaysinnormalsubjectsandinpatientswithdifferentdegreesofheartfailureJEndocrinolInvest1998;21(3):170-9

    41. Iervasi G., Manfredi C., Scarlattini M., Emdin M., Caratterizzazione e follow-up della funzione tiroidea nel paziente trattato con

    amiodaroneCardiolExtraosp1998;4:366-36942. ClericoA.,IervasiG.,DelRyS.,GiannessiD.,Immunoassaymethodsforthemeasurementofnatriureticcardiachormones-ANP,BNP,

    andrelatedpeptides-inhumansJClinicalLigandAssay1999;22:194-20443. ClericoA.,IervasiG.,MarianiG.,Pathophysiologyrelevanceofmeasuringtheplasmalevelsofcardiacnatriureticpeptidehormones

    inhumansHormMetabRes1999;31(9):487-9844. ClericoA.,IervasiG.,PiloA.Turnoverstudiesoncardiacnatriureticpeptides:methodological,pathophysiologicalandtherapeutical

    considerationsCurrentDrugMetabolism2000;1:85-105

  • Page 8 - Curriculum vitae of Giorgio Iervasi [email protected]

    45. EmdinM.,PrataliL.andIervasiG.AbolishedvagaltoneassociatedwiththyrotoxicosistriggersprinzmetalvariantparoxysmalatrialfibrillationAnnInternMed2000;132(8):679

    46. SabatinoL., IervasiG.,FerrazziP.,FrancesconiD.,ChopraI.J.Astudyof iodothyronine5’-monodeiodinaseactivities innormaland

    pathologicaltissuesinmanandtheircomparisonwithactivitiesinrattissuesLifeSciences2000;68:191-20247. Colzani R.M., Emdin M., Conforti F., Passino C., Scarlattini M. and Iervasi G. Hypertyroidism is associated with lenghtening of

    ventricularrepolarizationClinEndocrinol2001;55(1):27-3248. Sabatino L., Chopra I.J., Tanavoli S., Iacconi P. and Iervasi G. A radioimmunoassay for type I iodothironine 5’-monodeiodinase in

    humantissuesThyroid2001;11(8):733-73949. Forini F., Paolicchi A., Pizzorusso T., Ratto G.M., Saviozzi M., Vanini V and Iervasi G. 3,5,3’-thiiodothyronine deprivation affects

    phenotypeandintracellular(Ca2+)IofhumancardiomyocytesincultureCardiovascRes2001;51(2):322-3050. Fommei E., Iervasi G. The role of thyroid hormone in blood pression homeostasis: evidence from short-term hypothyroidism in

    humans.JClinEndocrinolMetab2002;87:1996-200051. SabatinoL.,CerilloA.G.,RipoliA.,PiloA.,GlauberM.,IervasiG.IsthelowT3stateacrucialfactordeterminigtheoutcomeofcoronary

    arterybypasspatients?Evidencefromaclinicalpilotstudy.JEndocrinology2002;175:577-8652. Iervasi G., PingitoreA., Landi P., RacitiM., Ripoli A., ScarlattiniM., L’AbbateA., Donato L. Low-T3 syndrome: a strong prognostic

    predictorofdeathinpatientswithheartdisease.Circulation2003;107:708-71353. IervasiG.,PingitoreA.,LandiP.,RacitiM.,RipoliA.,ScarlattiniM.,L’AbbateA.,DonatoL.Lowtriiodothyronineandcardiovascular

    disease.Circulation2003;108(4):authorreplye29-3054. NicoliniG.,BalzanS.,ColzaniR.,ScarlattiniM.,TaddeiM.C.,andIervasiG.ErythrocyteNa+/K+-ATPaseisincreasedinsubjectswith

    subclinicalhypothyroidism.ClinicalEndocrinology2004;60:705-71055. Iervasi A., Iervasi G., Bottoni A., Boni G., Annichiarico C., Di Cecco P., and Zucchelli GC.Diagnostic performance of a new highly

    sensitivethyroglobulinimmunoassay.JournalofEndocrinology2004;182:287-29456. ForiniF.,NicoliniG.,BalzanS.,RattoGM.,MurziB.,VaniniV., IervasiG.Amiodaroneinhibitsthe3,5,3’-triiodothyronine-dependent

    increase of sodium potassium adenosine triphosphatase activity and concentration in human atrial myocardial tissue. Thyroid2004;14(7):491-497

    57. ScosciaE.,BaglioniS.,EslamiA.,IervasiG.,MontiS.,TodiscoT.Lowtriiodothyronine(T3)state:apredictorofoutcomeinrespiratory

    failure?Resultsofaclinicalpilotstudy.EuropeanJournalofEndocrinology2004;151(5):557-6058. Gasbarri A., Marchetti C., Iervasi G., Bottoni A., Nicolini A., Bartolazzi A., Carpi A. From the bench to the bedside. Galectin-3

    immunodetectionforimprovingthepreoperativediagnosisofthefollicularthyroidnodules.BiomedPharmacother2004;25:356-59

    59. ColantuoniA.,MarchiafavaPL.,LapiD.,ForiniFS.,IervasiG.Theeffectsoftetraiodothyronineandtriiodothyronineonhamstercheek

    pouchmicrocirculation.AmJPhysiolHeartCircPhysiol2005;288:H1931-193660. PingitoreA.,LandiP.,TaddeiMC.,RipoliA.,L’AbbateA., IervasiG.Triiodothyronine levels forriskstratificationofpatientswith

    chronicheartfailure.AmericanJournalofMedicine2005;118:2:132-3661. RipoliA.,PingitoreA.,FavilliB.,BottoniA.,TurchiS.,OsmanN.,DeMarchiD.,LombardiM.,L’AbbateA.,IervasiG.Doessubclinical

    hypothyroidismaffectcardiacpumpperformance?EvidencefromaMagneticResonanceImagingstudy.JACC2005;45:439-4562. SabatinoL.,ColantuoniA.,IervasiG.IstheVascularSystemaMainTargetforThyroidHormones?FromMolecularandBiochemical

    FindingstoClinicalPerspectives.CurrentVascularPharmacology2005;3:133-14563. PingitoreA.,IervasiG.Thyroid(dys)functioninheartfailure:isitapotentialtargetformedicaltreatment?Vascularhealthandrisk

    management2005;1(2):97-10064. PingitoreA.,IervasiG.Funzionetiroideaescompensocardiaco:dallenuoveevidenzeclinicheallepossibiliimplicazioniterapeutiche.

    RecentiProgressiinMedicina2005;96(11):535-54165. CarpiA.,NaccaratoAG.,IervasiG.,NicoliniA.,BevilacquaG.,ViacavaP.,CollecchiP.,LavraL.,MarchettiC.,SciacchitanoS.,Bartolazzi

    A.Largeneedleaspirationbiopsyandgalectin-3determinationinselectedthyroidnoduleswithindeterminatedFNA-cytology.BrJCancer2006;95(2):204-9

    66. IervasiA.,IervasiG.,CarpiA.,ZucchelliGC.Serumthyroglobulinmeasurement:clinicalbackgroundandmainmethodologicalaspects

    withclinicalimpact.Biomedicine&Pharmacotheraphy2006;60:414-42467. PingitoreA., Iervasi G., BarisonA., Prontera C., Pratali L., EmdinM., GiannessiD., NegliaD. Early activation of an altered thyroid

    hormoneprofile inasymptomaticormildlysymptomatic idiopathic leftventricular dysfunction. JournalofCardiacFailure2006;12(7):520-526

    68. Franchi D., Iervasi G., Cini D., Benassi A., Cristofani R. Modello computerizzato per la Valutazione Integrata del Rischio

    Cardiovascolare(VIRC):fattorinotiedemergenti.RivistaItalianad’Igiene2006;66(1-2):7-25

  • Page 9 - Curriculum vitae of Giorgio Iervasi [email protected]

    69. IervasiG.Thyroidandheartfailure.Thyroidology2006;17:1-970. CarpiA.,NicoliniA.,MarchettiC., IervasiG.,AntonelliA.,CarpiF.Percutaneous largeneedleaspirationbiopsyofpalpable thyroid

    nodules:technicalanddiagnosticperformance.Histopathology2007;51:249-25771. IervasiG.,MolinaroS.,LandiP.,TaddeiM.C.,GalliE.,MarianiF.,L’AbbateA.,PingitoreA.Associationbetweenincreasedmortalityand

    mildthyroiddysfunctionincardiacpatients.ArchInternMed2007;167(14):1526-153272. IervasiA.,IervasiG.,FerdeghiniM.,SolimeoC.,BottoniA.,RossiL.,ColatoC.,ZucchelliG.C.ClinicalrelevanceofhighlysensitiveTg

    assayinmonitoringpatientstreatedfordifferentiatedthyroidcancer.ClinicalEndocrinology2007;67(3):434-44173. SabatinoL.,GliozheniE.,MolinaroS.,BonottiA.,AzzolinaS.,PopoffG.,CarpiA.,IervasiG.ThyroidhormonereceptorandIGF1/IGFR

    systems:Possiblerelationsinthehumanheart.BiomedPharmacother2007;61(8):457-62.Epub2007May22.74. Balzan S., Nicolini G., Forini F., Boni G., Del Carratore R., Nicolini A., Carpi A., Iervasi G.Presence of a functional TSH receptor on

    humanerythrocytes.BiomedPharmacother2007;61(8):463-7.Epub2007May25.75. PingitoreA.,DiBellaG.,LombardiM.,IervasiG.,StrataE.,AquaroG.D.,PositanoV.,DeMarchiD.,RossiG.,L'AbbateA.,RovaiD.The

    obesityparadoxandmyocardialinfarctsize.JCardiovascMed(Hagerstown).2007Sep;8(9):713-776. Pingitore A., Iervasi G. Triiodothyronine (T3) effects on cardiovascular system in patients with heart failure. Recent Patents on

    CardiovascularDrugDiscovery2008;3:(1):19-27.Review.77. PingitoreA.,GalliE.,BarisonA.,IervasiA.,ScarlattiniM.,NucciD.,L'AbbateA.,MariottiR.,IervasiG.Acuteeffectsoftriiodothyronine

    replacement therapy in patientswith chronic heart failure and low-t3 syndrome: a randomized, placebo-controlled study. J ClinEndocrinolMetab.2008;93(4):1351-8

    78. CarpiA.,DiCoscioG.,IervasiG.,AntonelliA.,MechanickJ.,SciacchitanoS.,NicoliniA.Thyroidfineneedleaspiration:Howtoimprove

    clinicians'confidenceandperformancewiththetechnique.CancerLett.2008;264(2):163-17179. IervasiG.Iltumoredifferenziatotiroideo:principididiagnosi,stadiazioneetrattamento.LigandAssay2008;13(3):191-19680. Balzan S., Frascarelli S., Nicolini G., Lubrano V., Forini F., Iervasi G., Zucchi R., Montali U. Acute infusion of recombinant human

    thyrotropininLangendorff-rathearts:Roleofathyrotropinreceptor.IntJCardiol.2009Jul;27(5):259-6381. Passino C., Pingitore A., Landi P., Iervasi G. Prognostic value of combined measurement of brain natriuretic peptide and

    triiodothyronineinheartfailure.JCardFail.2009Feb;15(1):35-40.Epub2008Oct4.82. GimelliA.,RossiG.,LandiP.,MarzulloP.,IervasiG.,L'AbbateA.,RovaiD.Stress/RestMyocardialPerfusionAbnormalitiesbyGated

    SPECT:StilltheBestPredictorofCardiacEventsinStableIschemicHeartDisease.JNuclMed.2009Mar16.83. Balzan S, Del Carratore R, Nicolini G, Forini F, Lubrano V, Simili M, Benedetti PA, Iervasi G TSH induces co-localization of TSH

    receptorandNa/K-ATPaseinhumanerythrocytes.CellBiochemFunct.2009:22;27(5):259-263.[Epubaheadofprint]84. NannipieriM.,CecchettiF.,AnselminoM.,NicoliniG.,LaMacchiaS.,CamastraS.,M.RossiM.,IervasiG.,FerranniniE.Expressionof

    thyrotropin and thyroid hormone receptors in adipose tissue of subjectswithmorbid obesity and/or type 2 diabetes: effects ofweightloss.InternationalJournalofObesity2009:33(9):1001-6

    85. Coceani M., Iervasi G., Pingitore A., Carpeggiani C., L’Abbate A. Thyroid hormone and coronary artery disease: from clinical

    correlationstoprognosticimplications.ClinCardiol2009:32(7):380-38586. Cini A., Carpi A., Mechanick J., Cini L., Camici M., Galetta F., Giardino R., Russo M.A., Iervasi G. Thyroid hormones and the

    cardiovascularsystem;pathophysiologyandinterventions.BiomedicineandPharmacotherapy2009;63:742-75387. Zucchelli G.C., Iervasi A., Ferdeghini M., Iervasi G. Serum thyroglobulin measurement in the follow-up of patients treated for

    differentiatedthyroidcancer.QJNuclMedMolImaging.2009Oct;53(5):482-9.88. Galli E., Pingitore A., Iervasi G. Thyroid hormone in the pathopysiology of heart failure: clinical evidence. Heart Fail Rev.

    2010;15(2):155-6989. LubranoV.,PingitoreA.,CarpiA.,IervasiG.Relationshipbetweentriiodothyronineandproinflammatorycytokinesinchronicheart

    failure.BiomedicineandPharmacotherapy2010Mar;64(3):165-990. Carpi A., Rossi G., Coscio G.D., Iervasi G., Nicolini A., Carpi F., Mechanick JI., Bartolazzi A. Galectin-3 detection on large-needle

    aspirationbiopsyimprovespreoperativeselectionofthyroidnodules:Aprospectivecohortstudy.AnnMed2010;42(1):70-891. CerilloA.G.,StortiS.,ClericoA., IervasiG.Thyroid functionandcardiacsurgery:whatshouldwemeasure,andwhen?AnnThorac

    Surg.2010Mar;89(3):1010-1.92. Pingitore A., Iervasi G., GerdesMA. Letter by Pingitore et al regarding article, "DITPA (3,5-diiodothyropropionic acid), a thyroid

    hormone analog to treat heart failure: phase II trial VeteransAffairs cooperative study". Circulation. 2010Mar16;121(10):e240;authorreplye241

  • Page 10 - Curriculum vitae of Giorgio Iervasi [email protected]

    93. GerdesM.A., IervasiG. Thyroid replacement therapy andheart failure. ContemporaryReviews inCardiovascularMedicine series.Circulation2010;122(4):385-393

    94. RodondiN.,DenElzenWP.,BauerD.C.,CappolaA.R.,RazviS.,WalshJ.P.,AsvoldB.O.,IervasiG.,ImaizumiM.,ColletT.H.,BremnerA.,

    Maisonneuve P., Sgarbi J.A., KhawK.T., VanderpumpM.P., Newman A.B., Cornuz J., Franklyn J.A.,Westendorp R.G., Vittinghoff E.,Gussekloo J., for the Thyroid Studies Collaboration. Subclinical Hypothyroidism and the Risk of Coronary Heart Disease andMortality.JAMA2010Sep22;304(12):1365-1374.

    95. IervasiG.,ClericoA.Harmonizationoffreethyroidhormonetests:amissionimpossible?ClinChemMed2011;4996. FranchiD,CiniD, IervasiG.AnewWeb-basedmedical tool forassessmentandpreventionof comprehensivecardiovascular risk.

    TherClinRiskManag.2011;7:59-68.Epub2011Feb17.97. PingitoreA,ChenY,GerdesAM,IervasiG.Acutemyocardialinfarctionandthyroidfunction:Newpathophysiologicalandtherapeutic

    perspectives.AnnMed.2011May1398. CoceaniM,MolinaroS,ScaleseM,LandiP,CarpeggianiC,L'AbbateA,IervasiG,PingitoreA.Thyroidhormone,amiodaronetherapy,

    andprognosisinleftventricularsystolicdysfunction.JEndocrinolInvest.2011;34(6):e144-14899. Giovannini S, Zucchelli GC, Iervasi G, Iervasi A, Chiesa MR, Mercuri A, Renieri A, Prontera C, Conte R, Clerico A. Multicentre

    comparisonoffreethyroidhormonesimmunoassays:theImmunocheckstudy.ClinChemLabMed2011;49100. Mourouzis I , ForiniF ,PantosC , IervasiG .Thyroidhormoneandcardiacdisease : frombasic concepts to clinical application J

    ThyroidRes.2011;2011:958626.Epub2011Jun19.101. BalzanS,CarpiA,EvangelistaM,NicoliniG,PollastriA,BottoniA,IervasiG.AcuteeffectofTSHonoxygenationstateandvolumeof

    erythrocytesfromsubjectsthyroidectomizedfordifferentiatedthyroidcarcinoma.iomedPharmacother.2011;65(5):381-4.Epub2011Jun17.

    102. ForiniF.,LionettiV.,ArdehaliH.,PucciA.,CecchettiF.,GhanefarM.,NicoliniG.,IchikawaY.,NannipieriM.,RecchiaF.A,IervasiG.Early

    long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodeling in rats. J Cell Mol Med. 2011Mar;15(3):514-24

    103. DelCarratoreR,CarpiA,BeffyP,LubranoV,GiorgettiL,MasertiBE,CarluccioMA,SimiliM,IervasiG,BalzanS.Itraconazoleinhibits

    HMEC-1angiogenesis.BiomedicineandPharmacotherapy2012;66(4):312-317104. MolinaroS,IervasiG,LorenzoniV,CoceaniM,LandiP,SrebotV,MarianiF,L’AbbateA,PingitoreA.PersistenceofMortalityRiskin

    PatientsWithAcuteCardiacDiseasesandMildThyroidDysfunction.AmJMedSci.2012;343(1):65-70105. GalliE,MarchiniM,SabaA,BertiS,TonaccheraM,VittiP,ScanlanTS,IervasiG,ZucchiR.Detectionof3-IodothyronamineinHuman

    Patients:APreliminaryStudy.JClinEndocrinolMetab.2012;97(1):E69-E74Oct26106. BalzanS,DelCarratoreR,NicoliniG,BeffyP, LubranoV,ForiniF, IervasiG.Proangiogenic effectofTSH inhumanmicrovascular

    endothelialcellstroughtitsmembranereceptor.JClinEndocrinolMetab.2012;97(5):1763-1770107. MarchettiI,IervasiG,MazzantiMC,LessiF,TomeiS,NaccaratoAG,AretiniP,AlbertiB,DiCoscioG,andBevilacquaG.Detectionof

    the BRAFV600E mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manualmacrodissection:aneasytooltoimprovethepreoperativediagnosis.Thyroid2012;22(3):292-298

    108. IervasiG,ForiniF,SabatinoL.Aglassofwine:howgoodisgood?Theresveratrollesson.CritCareMed2012;40(11):3098-99109. IervasiG,BottoniA,FilideiE.IsrecombinanthumanTSHaseffectiveasthyroidhormonewithdrawalindetectionandtreatmentof

    metastaticdifferentiatedthyroidcancer?ExpertReviewofEndocrinologyandMetabolism2012;7(12):633-35110. ColletTH,GusseklooJ,BauerDC,denElzenWP,CappolaAR,BalmerP,IervasiG,ÅsvoldBO,SgarbiJA,VölzkeH,GencerB,MacielRM,

    Molinaro S, Bremner A, Luben RN,Maisonneuve P, Cornuz J, Newman AB, KhawKT,Westendorp RG, Franklyn JA, Vittinghoff E,Walsh JP, Rodondi N; Thyroid Studies Collaboration. Subclinical hyperthyroidism and the risk of coronary heart disease andmortality.ArchInternMed.2012May28;172(10):799-809.

    111. Fontana M., Passino C., Poletti R., Zyw L., Prontera C., Scarlattini M., Clerico A., Emdin M., Iervasi G. Low Triiodothyronine and

    exercisecapacityinheartfailure.InternationalJournalofCardiology2012112. CantinottiM,LorenzoniV,StortiS,MoschettiR,MurziB,MarottaM,CrocettiM,MolinaroS,ClericoA,PortmanM,IervasiG.Thyroid

    andbrainnatriueticpeptideresponseinchildrenundergoingcardiacsurgeryforcongenitalheartdisease:age-relatedvariationsandprognosticvalue.CirculationJournal2013;77(1):188-97

    113. Marraccini P, Bianchi M, Bottoni A, Mazzarisi A, Coceani M, Molinaro S, Lorenzoni V, Landi P, Iervasi G. Prevalence of thyroid

    disfunction and effect of contrastmedium on thyroidmetabolism in cardiac patients undergoing on coronary angiography. ActaRadiologica2013;54(1):42-47

    114. Iervasi G., Nicolini G. Thyroid hormone and cardiovascular system: from basic concepts to clinical application. Internal and

    EmergencyMedicine,2013;8:71-74115. Vassalle C., Iervasi G. Cathepsin K – A classical bone biomarker in cardiovascular disease: the heart is not alone anymore.

    Atherosclerosis2013;228:36-37

  • Page 11 - Curriculum vitae of Giorgio Iervasi [email protected]

    116. NicoliniG,PittoL,KusmicC,BalzanS,SabatinoL,IervasiG,ForiniF.Newinsightintomechanismofcardioprotectionmediatedbythyroidhormones.JournalofThyroidResearch2013;2013:264387

    117. CarpiA, RossiG,NicoliniA, IervasiG, RussoM,Mechanick J.Does largeneedle aspirationbiopsy addpain to the thyroidnodule

    evaluation?PLoSOne.2013;8(3):e58016.118. CantinottiM,ClericoA, IervasiG.Age-anddisease-relatedvariations inB-typenatriureticpeptideresponseafterpediatriccardiac

    surgery.JThoracCardiovascSurg.2013May;145(5):1415-16119. Adamopoulos S, Gouziouta A,Mantzouratou P, Laoutaris ID, Dritsas A, CokkinosDV,Mourouzis I, Sfyrakis P, Iervasi G, Pantos C.

    Thyroidhormonesignalingisalteredinresponsetophysicaltraininginpatientswithend-stageheartfailureandmechanicalassistdevices:potentialphysiologicalconsequences?InteractCardiovascThoracSurg2013;17(4):664-68

    120. MenicucciD,SebastianiL,CompariniA,PingitoreA,GhelarducciB,L’AbbateA,IervasiG,GemignaniA.Minimalchangesofthyroid

    axis activity influence brain functions in young females affected by subclinical hypothyroidism. Archives Italiennes de Biologie2013;151:1-10

    121. Cantinotti M, Iervasi G, Clerico A. B-type natriuretic peptide in children undergoing pediatric cardiac surgery: just a marker of

    diseaseseveritystronglyrelatedtoageormuchmore?TheJournalofThoracicandCardiovascularSurgery2014;147(1):541122. WeltmanNY,PingitoreA, IervasiG.Relationof triiodothyronine tosubclinicalmyocardial injury inpatientswithchestpain.AmJ

    Cardiology2013;112(3):465-66123. CantinottiM,AssantaN,MurziB,IervasiG,SpadoniI.Echocardiographicdefinitionofrestrictivepatentforamenovale(PFO).Heart

    2014;100:264-265124. BalzanS,DelCarratoreS,Nardulli C, SabatinoL, SabatinoL, IervasiG.The stimulative effect ofT3andT4onhumanmyocardial

    endothelialcellproliferation,migrationandangiogenesis.JClinExpCardiology2013;4:12125. Saba A, Donzelli R, Colligiani D, Raffaelli A, Nannipieri M, Kusmic C, Dos Remedios CG, Simonides WS, Iervasi G, Zucchi R.

    QuantificationofThyroxineand3,5,3’–TriiodothyronineinHumanandAnimalHeartsbyaNovelLiquidChromatography-TandemMassSpectometryMethod.HormMetabRes2014;46:1-7

    126. CerilloAG,StortiS,KallushiE,HaxhiademiD,MiceliA,MurziM,BertiS,GlauberM,ClericoA, IervasiG.The lowtriiodothyronine

    syndrome: a strong predictor of low cardiac output and death in patients undergoing coronary artery bypass grafting. Annals ofThoracicSurgery2014

    127. CantinottiM,ScaleseM,MurziB,AssantaN,Spadoni I,FestaP,DeLuciaV,CrocettiM,MarottaM,MolinaroS,LopezL, IervasiG.

    Echocardiographic nomograms for ventricular, valvular and arterial dimensions in caucasian children with a special focus onneonates,infantsandtoddlers.JAmSocEchocardiography2014;27(2):179-181

    128. CantinottiM,AssantaN,CrocettiM,MarottaM,MurziB,IervasiG.Limitationsofcurrentnomogramsinpediatricechocardiography:

    justthetipoftheiceberg-acallforstandardization.JAmSocEchocardiography2014;27(3):339129. GuiducciL,IervasiG,QuininesGalvanA.Ontheparadoxinsulinresistance/insulinhypersensivityandobesity:twotalesofthesame

    story.ExpRevCardiovasc.Ther.201412(6):637:642130. ArviaC,SicilianoV,ChatzianagnostouK,LawsG,QuinonesGalvanA,MamminiC,BertiS,MolinaroS,IervasiG;Conventionalinsulin

    vs insulin infusion therapy in acute coronary syndrome diabetic patients; World J Diabetes. 2014 Aug 15;5(4):562-8. doi:10.4239/wjd.v5.i4.562

    131. SabatinoL,IervasiG,PingitoreA;Thyroidhormoneandheartfailure:frommyocardialprotectiontosystemicregulation.;ExpertRev

    CardiovascTher.2014Oct;12(10):1227-36.doi:10.1586/14779072.2014.957674.Epub2014Sep1132. Forini F, Kusmic C, Nicolini G, Mariani L, Zucchi R, Matteucci M, Iervasi G, Pitto L; Triiodothyronine prevents cardiac

    ischemia/reperfusion mitochondrial impairment and cell loss by regulating miR30a/p53 axis. Endocrinology.2014Nov;155(11):4581-90.doi:10.1210/en.2014-1106.Epub2014Aug19.

    133. SabatinoL,LubranoV,BalzanS,KusmicC,DelTurcoS, IervasiG.ThyroidhormonedeiodinasesD1,D2,andD3areexpressed in

    human endothelial dermal microvascular line: effects of thyroid hormones. Mol Cell Biochem.2015 Jan;399(1-2):87-94. doi:10.1007/s11010-014-2235-8.Epub2014Oct11.

    134. BuneviciusA,IervasiG,BuneviciusR.Neuroprotectiveactionsofthyroidhormonesandlow-T3syndromeasabiomarkerinacute

    cerebrovasculardisorders.ExpertRevNeurother.2015Mar;15(3):315-26.doi:10.1586/14737175.2015.1013465.Epub2015Feb11.

    135. ForiniF,NicoliniG,IervasiG.Mitochondriaaskeytargetsofcardioprotectionincardiacischemicdisease:roleofthyroidhormone

    triiodothyronine.IntJMolSci.2015Mar19;16(3):6312-36.doi:10.3390/ijms16036312.

  • Page 12 - Curriculum vitae of Giorgio Iervasi [email protected]

    135. ChakerL,BaumgartnerC,denElzenWP,IkramMA,BlumMR,ColletTH,BakkerSJ,DehghanA,DrechslerC,LubenRN,HofmanA,PortegiesML,MediciM,IervasiG,StottDJ,FordI,BremnerA,WannerC,FerrucciL,NewmanAB,DullaartRP,SgarbiJA,CeresiniG,Maciel RM,WestendorpRG, Jukema JW, ImaizumiM, Franklyn JA, BauerDC,Walsh JP, Razvi S, KhawKT, Cappola AR, VölzkeH,FrancoOH,Gussekloo J,RodondiN,PeetersRP;ThyroidStudiesCollaboration.SubclinicalHypothyroidismandtheRiskofStrokeEvents and Fatal Stroke: An Individual Participant Data Analysis. J Clin Endocrinol Metab. 2015 Jun;100(6):2181-91. doi:10.1210/jc.2015-1438.Epub2015Apr9.

    137. Cantinotti M, Giordano R, Scalese M, Molinaro S, Murzi B, Assanta N, Crocetti M, Marotta M, Ghione S, Iervasi G. Strengths and

    limitations of current pediatric bloodpressurenomograms: a global overviewwith a special emphasis on regional differences inneonatesandinfants.HypertensRes.2015Sep;38(9):577-87.doi:10.1038/hr.2015.45.Epub2015Apr16.

    138. Åsvold BO, Vatten LJ, Bjøro T, BauerDC, Bremner A, Cappola AR, Ceresini G, den ElzenWP, Ferrucci L, FrancoOH, Franklyn JA,

    GusseklooJ,IervasiG,ImaizumiM,KearneyPM,KhawKT,MacielRM,NewmanAB,PeetersRP,PsatyBM,RazviS,SgarbiJA,StottDJ,TrompetS,VanderpumpMP,VölzkeH,WalshJP,WestendorpRG,RodondiN;ThyroidStudiesCollaboration.Thyroidfunctionwithinthenormalrangeandriskofcoronaryheartdisease:anindividualparticipantdataanalysisof14cohorts.JAMAInternMed.2015Jun;175(6):1037-47.doi:10.1001/jamainternmed.2015.0930.

    139. CantinottiM,GiordanoR,ScaleseM,MolinaroS,DellaPinaF,StortiS,ArcieriL,MurziB,MarottaM,PakV,PoliV,IervasiG,KuttyS,Clerico A. Prognostic role of BNP in children undergoing surgery for congenital heart disease: analysis of prediction modelsincorporatingstandardriskfactors.ClinChemLabMed.2015Oct1;53(11):1839-46.doi:10.1515/cclm-2014-1084.

    140. CantinottiM,KuttyS,GiordanoR,AssantaN,MurziB,CrocettiM,MarottaM, IervasiG.Reviewandstatus reportofpediatric left

    ventricularsystolicstrainandstrainratenomograms.HeartFailRev.2015Sep;20(5):601-12.doi:10.1007/s10741-015-9492-9.141. WangW,GuanH,GerdesAM,IervasiG,YangY,TangYD.ThyroidStatus,CardiacFunction,andMortalityinPatientsWithIdiopathic

    DilatedCardiomyopathy.JClinEndocrinolMetab.2015Aug;100(8):3210-8.doi:10.1210/jc.2014-4159.Epub2015Jun8.142. PingitoreA, LimaGP,Mastorci F, QuinonesA, Iervasi G, Vassalle C. Exercise and oxidative stress: potential effects of antioxidant

    dietarystrategiesinsports.Nutrition.2015Jul-Aug;31(7-8):916-22.doi:10.1016/j.nut.2015.02.005.Epub2015Feb19.143. FusaroM,GianniniS,GallieniM,NoaleM,TripepiG,RossiniM,MessaP,RigottiP,PatiT,BarbisoniF,PiccoliA,AghiA,AlessiM,

    Bonfante L, Fabris F, Zambon S, Sella S, Iervasi G, PlebaniM. Calcimimetic and vitaminD analog use in hemodialyzedpatients isassociatedwithincreasedlevelsofvitaminKdependentproteins.Endocrine.2015Jul1.[Epubaheadofprint]

    144. ChatzianagnostouK, IervasiG,VassalleC.ChallengesofLADADiagnosisandTreatment:LessonsFrom2CaseReports.AmJTher.

    2015Sep24.[Epubaheadofprint]145 PingitoreA,NicoliniG,KusmicC,IervasiG,GrigoliniP,ForiniF.CardioprotectionandthyroidhormonesHeartFailRev.2016Mar24.

    [Epubaheadofprint]146 Sbrana F, Genovesi D, Catapano GA, Panchetti L, Bottoni A, Iervasi G. Dabigatran malabsorption in amiodarone-induced

    thyrotoxicosis:aclinicalreport.InternEmergMed.2016Mar17.[Epubaheadofprint]147 NicoliniG,ForiniF,KusmicC,PittoL,MarianiL,IervasiG.Earlyandshort-termtriiodothyroninesupplementationpreventsadverse

    post-ischemiccardiacremodeling:roleoftransforminggrowthfactor-β1andanti-fibroticmiRNAsignaling.MolMed.2015Nov23.doi:10.2119/molmed.2015.00140.[Epubaheadofprint]

    148 CantinottiM,GiordanoR,ScaleseM,MurziB,AssantaN,SpadoniI,CrocettiM,MarottaM,MolinaroS,KuttyS,IervasiG.Nomograms

    formitral inflowDopplerandtissueDopplervelocities inCaucasianchildren. JCardiol.2015Nov9.pii:S0914-5087(15)00321-4.doi:10.1016/j.jjcc.2015.10.004.[Epubaheadofprint]

    149 ForiniF,UcciferriN,KusmicC,NicoliniG,CecchettiniA,RocchiccioliS,CittiL,IervasiG.EvidencefromaProteomicApproach.Low

    T3 State Is Correlated with Cardiac Mitochondrial Impairments after Ischemia Reperfusion Injury: Int J Mol Sci. 2015 Nov6;16(11):26687-705.doi:10.3390/ijms161125973.

    150 FusaroM,PlebaniM,IervasiG,GallieniM.VitaminKDeficiencyinChronicKidneyDisease:EvidenceIsBuildingUp.AmJNephrol.

    2016Nov15;45(1):1-3.[Epubaheadofprint]151 JabbarA,PingitoreA,PearceSH,ZamanA,IervasiG,RazviS.Thyroidhormonesandcardiovasculardisease.NatRevCardiol.2016

    Nov4.doi:10.1038/nrcardio.2016.174.[Epubaheadofprint]152 ChakerL,BaumgartnerC,denElzenWP,ColletTH,IkramMA,BlumMR,DehghanA,DrechslerC,LubenRN,PortegiesML,IervasiG,

    MediciM,StottDJ,DullaartRP,FordI,BremnerA,NewmanAB,WannerC,SgarbiJA,DörrM,LongstrethWTJr,PsatyBM,FerrucciL,MacielRM,WestendorpRG, JukemaJW,CeresiniG, ImaizumiM,HofmanA,BakkerSJ,Franklyn JA,KhawKT,BauerDC,Walsh JP,Razvi S, Gussekloo J, VölzkeH, FrancoOH, CappolaAR, RodondiN, PeetersRP; Thyroid Studies Collaboration.. Thyroid FunctionWithin the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis. J Clin Endocrinol Metab. 2016Nov;101(11):4270-4282.

    153 FusaroM,GallieniM,RizzoMA,StucchiA,DelanayeP,CavalierE,MoysésRM,JorgettiV,IervasiG,GianniniS,FabrisF,AghiA,SellaS,

    Galli F, Viola V, Plebani M. Vitamin K plasma levels determination in human health. Clin Chem Lab Med. 2016 Oct 12. pii:/j/cclm.ahead-of-print/cclm-2016-0783/cclm-2016-0783.xml.doi:10.1515/cclm-2016-0783.[Epubaheadofprint]

    154 SabatinoL,KusmicC,NicoliniG,AmatoR,CasiniG,IervasiG,BalzanS.T3enhancesAng2inrataortainmyocardialI/R:comparison

    withleftventricle.JMolEndocrinol.2016Oct;57(3):139-49.doi:10.1530/JME-16-0118.

  • Page 13 - Curriculum vitae of Giorgio Iervasi [email protected]

    155 FusaroM,D'AlessandroC,NoaleM,TripepiG,PlebaniM,VeroneseN,IervasiG,GianniniS,RossiniM,TarroniG,LucatelloS,VianelloA, Santinello I, Bonfante L, Fabris F, Sella S, PiccoliA,NasoA, CiurlinoD,AghiA,GallieniM, CupistiA. LowvitaminK1 intake inhaemodialysispatients.ClinNutr.2016Apr28.pii:S0261-5614(16)30070-X.doi:10.1016/j.clnu.2016.04.024.[Epubaheadofprint]

    156 CantinottiM,GiordanoR,ScaleseM,MurziB,AssantaN,SpadoniI,MauraC,MarcoM,MolinaroS,KuttyS,IervasiG.Nomogramsfor

    two-dimensional echocardiography derived valvular and arterial dimensions in Caucasian children. J Cardiol. 2016 Apr 23. pii:S0914-5087(16)30029-6.doi:10.1016/j.jjcc.2016.03.010.[Epubaheadofprint]

    157 CantinottiM,AssantaN,CrocettiM,SpadoniI,IervasiG.ChallengesinInterpretingPediatricNormativeLeftVentricularStrainData

    and the Quest for Comprehensive Deformation Nomograms. J Am Soc Echocardiogr. 2016 Jun;29(6):567-8. doi:10.1016/j.echo.2016.03.005.

    158 Donzelli R, Colligiani D, Kusmic C, Sabatini M, Lorenzini L, Accorroni A, Nannipieri M, Saba A, Iervasi G, Zucchi R. Effect of

    HypothyroidismandHyperthyroidismonTissueThyroidHormoneConcentrationsinRat.EurThyroidJ.2016Mar;5(1):27-34.doi:10.1159/000443523.

    159 CantinottiM,GiordanoR,ClementeA,AssantaN,MurziM,MurziB,CrocettiM,MarottaM,ScaleseM,KuttyS,IervasiG.Strengthsand

    LimitationsofCurrentAdultNomograms for theAortaObtainedbyNoninvasiveCardiovascular Imaging.Echocardiography.2016Jul;33(7):1046-68.doi:10.1111/echo.13232.Review.

    160 WangW,GuanH,FangW,ZhangK,GerdesAM,IervasiG,TangYD.FreeTriiodothyronineLevelCorrelateswithMyocardialInjury

    and Prognosis in Idiopathic Dilated Cardiomyopathy: Evidence from Cardiac MRI and SPECT/PET Imaging. Sci Rep. 2016 Dec22;6:39811.doi:10.1038/srep39811.

    161 Bunevicius A, Deltuva VP, Tamasauskas S, Smith T, Laws ER, Bunevicius R, Iervasi G, Tamasauskas A.Preoperative low tri-

    iodothyronineconcentrationisassociatedwithworsehealthstatusandshorterfiveyearsurvivalofprimarybraintumorpatients.Oncotarget.2017Jan31;8(5):8648-8656.doi:10.18632/oncotarget.14376.

    162 CantinottiM,KuttyS,FranchiE,PaterniM,ScaleseM,IervasiG,KoestenbergerM.Pediatricechocardiographicnomograms:Whathas

    beendoneandwhatstillneedstobedone.TrendsCardiovascMed.2017Jul;27(5):336-349.doi:10.1016/j.tcm.2017.01.006.Epub2017Jan19.Review.

    163 ClericoA,RipoliA,FortunatoA,AlfanoA,CarrozzaC,CorrealeM,DittadiR,GessoniG,MigliardiM,RizzardiS,PronteraC,MasottiS,

    ZucchelliG,GuiottoC,IacovazziPA,IervasiG.HarmonizationprotocolsforTSHimmunoassays:amulticenterstudyinItaly.ItalianSectionoftheEuropeanLigandAssaySociety(ELAS).ClinChemLabMed.2017Oct26;55(11):1722-1733.doi:10.1515/cclm-2016-0899.

    164 FerranniniE,IervasiG,CobbJ,NdreuR,NannipieriM.Insulinresistanceandnormalthyroidhormonelevels:prospectivestudyand

    metabolomic analysis. Am J Physiol Endocrinol Metab. 2017 May 1;312(5):E429-E436. doi: 10.1152/ajpendo.00464.2016. Epub2017Feb28.

    165 CantinottiM,GiordanoR,EmdinM,AssantaN,CrocettiM,MarottaM,IervasiG,LopezL,KuttyS.Echocardiographicassessmentof

    pediatric semilunar valve disease. Echocardiography. 2017 Sep;34(9):1360-1370. doi: 10.1111/echo.13527. Epub 2017 Mar 31.Review.

    166 Cantinotti M, Giordano R, Scalese M, Molinaro S, Storti S, Murzi B, Pak V, Poli V, Iervasi G, Clerico A. Diagnostic accuracy and

    prognosticvaluedofplasmaticCystatin-Cinchildrenundergoingpediatriccardiacsurgery.ClinChimActa.2017Aug;471:113-118.doi:10.1016/j.cca.2017.05.031.Epub2017May26.

    167 Cantinotti M, Giordano R, Assanta N, Murzi B, Melo M, Franchi E, Crocetti M, Iervasi G, Kutty S. Strengths, Limitations, and

    GeographicalDiscrepanciesintheEligibilityCriteriaforSportParticipationinYoungPatientsWithCongenitalHeartDisease.ClinJSportMed.2017Jul21.doi:10.1097/JSM.0000000000000474.[Epubaheadofprint]

    168 CantinottiM, GiordanoR, ScaleseM, Franchi E, CoranaG, AssantaN,Maura C,MarcoM,Molinaro S, KoestenbergerM, Iervasi G.

    Nomogramsforechocardiographicrightventricularsub-costalviewdimensionsinhealthyCaucasianchildren:Anewapproachtomeasuretherightventricle.JCardiol.2018Feb;71(2):181-186.doi:10.1016/j.jjcc.2017.07.015.Epub2017Oct12.

    169 FusaroM,GallieniM,AghiA,IervasiG,RizzoMA,StucchiA,NoaleM,TripepiG,NickolasT,VeroneseN,FabrisF,GianniniS,CalòL,

    PiccoliA,MereuMC,CosmaiL,FerraroA,MagonaraF,SpinelloM,SellaS,PlebaniM.CigarettesmokingisassociatedwithdecreasedBone Gla-protein (BGP) levels in hemodialysis patients. Curr Vasc Pharmacol. 2017 Sep 19. doi:10.2174/1570161115666170919182421.[Epubaheadofprint]

    170 Guarino D, Nannipieri M, Iervasi G, Taddei S, Bruno RM. The Role of the Autonomic Nervous System in the Pathophysiology of

    Obesity.FrontPhysiol.2017Sep14;8:665.doi:10.3389/fphys.2017.00665.eCollection2017.Review.171 Hartwig V, Guiducci L,MarinelliM, Pistoia L, Tegrimi TM, Iervasi G, Quinones-GalvanA, L'Abbate A.Multimodal Imaging for the

    Detection of Brown Adipose Tissue Activation inWomen: A Pilot Study Using NIRS and Infrared Thermography. J Healthc Eng.2017;2017:5986452.doi:10.1155/2017/5986452.Epub2017Sep14.

    172 BuneviciusA,DeltuvaV,LawsER, IervasiG,TamsauskasA,BuneviciusR.PreoperativeN-terminalpro-B-typenatriureticpeptide

    concertationandprognosisofbraintumorpatients:a5-yearfollowupstudy.SciRep.2017Nov7;7(1):14775.doi:10.1038/s41598-017-15394-6.

  • Page 14 - Curriculum vitae of Giorgio Iervasi [email protected]

    173 Cantinotti M, Giordano R, Corsini I, Dani C, Scalese M, Murzi B, Assanta N, Spadoni I, Molinaro S, Kutty S, Iervasi G, Franchi E.EchocardiographicnomogramsforupperabdominalaortaDopplersystolicwavevaluesandsysto-diastolicdiametersvariationsinchildren.JCardiol.2018Apr;71(4):394-400.doi:10.1016/j.jjcc.2017.09.016.Epub2017Nov10.

    174 FusaroM,MereuMC,AghiA,IervasiG,GallieniM.VitaminKandbone.ClinCasesMinerBoneMetab.2017May-Aug;14(2):200-206.

    doi:10.11138/ccmbm/2017.14.1.200.Epub2017Oct25.Review.175 ZhangK,WangW,ZhaoS,KatzSD,IervasiG,GerdesAM,TangYD.Long-termprognosticvalueofcombinedfreetriiodothyronineand

    lategadoliniumenhancementinnonischemicdilatedcardiomyopathy.ClinCardiol.2018Jan;41(1):96-103.doi:10.1002/clc.22858.Epub2018Jan23.

    176 Bunevicius A, Radziunas A, Tamasauskas S, Tamasauskas A, Laws ER, Iervasi G, Bunevicius R, Deltuva V. Prognostic role of high

    sensitivity C-reactive protein and interleukin-6 in glioma andmeningioma patients. J Neurooncol. 2018 Jun;138(2):351-358. doi:10.1007/s11060-018-2803-y.Epub2018Feb19.

    177 CantinottiM,ScaleseM,GiordanoR,FranchiE,AssantaN,MarottaM,ViacavaC,MolinaroS,IervasiG,SantoroG,KoestenbergerM.

    NormativeData for Left andRightVentricular Systolic Strain inHealthyCaucasian ItalianChildrenbyTwo-Dimensional Speckle-TrackingEchocardiography.JAmSocEchocardiogr.2018Jun;31(6):712-720.e6.doi:10.1016/j.echo.2018.01.006.Epub2018Mar8.

    178 Razvi S, Jabbar A, Pingitore A, Danzi S, Biondi B, Klein I, Peeters R, Zaman A, Iervasi G. Thyroid Hormones and Cardiovascular

    FunctionandDiseases.JAmCollCardiol.2018Apr24;71(16):1781-1796.doi:10.1016/j.jacc.2018.02.045.Review.179 MeuweseCL,vanDiepenM,CappolaAR,SarnakMJ,ShlipakMG,BauerDC,FriedLP,IacovielloM,VaesB,DegryseJ,KhawKT,Luben

    RN,ÅsvoldBO,BjøroT,VattenLJ,deCraenAJM,TrompetS,IervasiG,MolinaroS,CeresiniG,FerrucciL,DullaartRPF,BakkerSJL,JukemaJW,KearneyPM,StottDJ,PeetersRP,FrancoOH,VölzkeH,WalshJP,BremnerA,SgarbiJA,MacielRMB,ImaizumiM,OhishiW,DekkerFW,RodondiN,GusseklooJ,denElzenWPJ.Lowthyroidfunctionisnotassociatedwithanaccelerateddeteriorationinrenalfunction.ThyroidStudiesCollaboration.NephrolDialTransplant.2018Apr18.doi:10.1093/ndt/gfy071.[Epubaheadofprint]

    180 Sabatino L, Balzan S, Kusmic C, Iervasi G. Modification of gene expression profiling related to renin-angiotensin system in an

    ischemia/reperfusionratmodelafterT3infusion.MolCellBiochem.2018May8.doi:10.1007/s11010-018-3364-2.[Epubaheadofprint]

    181 Sabatino L, Costagli C, Lapi D, Del Seppia C, Federighi G, Balzan S, Colantuoni A,Iervasi G, Scuri R. Renin-Angiotensin System

    Responds to ProlongedHypotensive Effect Induced byMandibular Extension in SpontaneouslyHypertensive Rats. Front Physiol.2018Nov15;9:1613.doi:10.3389/fphys.2018.01613.eCollection2018.

    182 CantinottiM,ScaleseM,GiordanoR,FranchiE,AssantaN,MolinaroS,IervasiG,SantoroG,KoestenbergerM,KuttyS.LeftandRight

    AtrialStraininHealthyCaucasianChildrenbyTwo-DimensionalSpeckle-TrackingEchocardiography.JAmSocEchocardiogr.2019Jan;32(1):165-168.e3.doi:10.1016/j.echo.2018.10.002.Epub2018Nov17.

    183 CantinottiM,ScaleseM,GiordanoR,AssantaN,SantoroG,PaterniM,IervasiG,ChiappaE,KuttyS,KostenbergerM.Limitationsof

    Current Fetal Echocardiography Nomograms for 2D Measures: A Critical Overview and Analysis for Future Research. J Am SocEchocardiogr.2018Dec;31(12):1368-1372.e10.doi:10.1016/j.echo.2018.09.018.Epub2018Oct16.

    184 Forini F, Nicolini G, Kusmic C, D'Aurizio R, Rizzo M, Baumgart M, Groth M, Doccini S, Iervasi G, Pitto L. Integrative analysis of

    differentially expressed genes andmiRNAs predicts complex T3-mediated protective circuits in a rat model of cardiac ischemiareperfusion.SciRep.2018Sep14;8(1):13870.doi:10.1038/s41598-018-32237-0.

    185 GoriniF, IervasiG,CoiA,PittoL,BianchiF.TheRoleofPolybrominatedDiphenylEthers inThyroidCarcinogenesis: Is It aWeak

    HypothesisoraHiddenReality?FromFactstoNewPerspectives.IntJEnvironResPublicHealth.2018Aug24;15(9).pii:E1834.doi:10.3390/ijerph15091834.Review.

    186 WopereisDM,DuPuyRS,vanHeemstD,WalshJP,BremnerA,BakkerSJL,BauerDC,CappolaAR,CeresiniG,DegryseJ,DullaartRPF,

    FellerM,FerrucciL,FlorianiC,FrancoOH,IacovielloM,IervasiG,ImaizumiM,JukemaJW,KhawKT,LubenRN,MolinaroS,NauckM,PatelKV,PeetersRP,PsatyBM,RazviS,SchindhelmRK,vanSchoorNM,StottDJ,VaesB,VanderpumpMPJ,VölzkeH,WestendorpRGJ,RodondiN,CobbaertCM,GusseklooJ,denElzenWPJ;ThyroidStudiesCollaboration.TheRelationBetweenThyroidFunctionand Anemia: A Pooled Analysis of Individual Participant Data. J Clin Endocrinol Metab. 2018 Oct 1;103(10):3658-3667. doi:10.1210/jc.2018-00481.

    187 WangWY,ZhangK,ZhaoW,GerdesAM,IervasiG,TangYD.Freetriiodothyroninelevelcorrelateswithstatinresponsivenessinacute

    myocardialinfarction.JGeriatrCardiol.2018Apr;15(4):290-297.doi:10.11909/j.issn.1671-5411.2018.04.009.188 FusaroM,D'ArrigoG,PitinoA,IervasiG,TentoriF,RobinsonB,AghiA,BieberB,McculloghK,FabrisF,PlebaniM,GianniniS,Gallieni

    M,TripepiG. Increasedriskofbone fractures inhemodialysispatients treatedwithprotonpump inhibitors inrealworld: resultsfrom theDialysis Outcomes and Practice Patterns Study (DOPPS).J BoneMiner Res. 2019 Jul 31. doi: 10.1002/jbmr.3842. [Epubaheadofprint]

    189 ForiniF,NicoliniG,KusmicC,IervasiG.ProtectiveEffectsofEuthyroidismRestorationonMitochondriaFunctionandQualityControl

    inCardiacPathophysiology.IntJMolSci.2019Jul10;20(14).pii:E3377.doi:10.3390/ijms20143377.Review.190 CantinottiM,KoestenbergerM,SantoroG,AssantaN,FranchiE,PaterniM,IervasiG,D'AndreaA,D'AscenziF,GiordanoR,Galderisi

    M.Normalbasic2Dechocardiographicvaluestoscreenandfollowuptheathlete'sheartfromjuniorstoadults:Whatisknownandwhatismissing.Acriticalreview.EurJPrevCardiol.2019Jul2:2047487319862060.doi:10.1177/2047487319862060.[Epub

    191 Lubrano V, Pingitore A, Traghella I, Storti S, Parri S, Berti S, Ndreu R, Andrenelli A, Palmieri C,Iervasi G, Mastorci F, Vassalle C.

    Emerging Biomarkers of Oxidative Stress in Acute and Stable Coronary Artery Disease: Levels and Determinants. Antioxidants

  • Page 15 - Curriculum vitae of Giorgio Iervasi [email protected]

    (Basel).2019May1;8(5).pii:E115.doi:10.3390/antiox8050115.192 CantinottiM,ScaleseM,GiordanoR,FranchiE,MarcheseP,AssantaN,MolinaroS,PaterniM,IervasiG,KoestenbergerM,KuttyS.

    Three-DimensionalEchocardiographyDerivedNomogramsforLeftVentricularVolumesinHealthyCaucasianItalianChildren.JAmSocEchocardiogr.2019Jun;32(6):794-797.e1.doi:10.1016/j.echo.2019.01.020.Epub2019Apr2.Noabstractavailable.

    193 CantinottiM,GiordanoR,ScaleseM,FranchiE,AssantaN,MolinaroS,MarcheseP,PaterniM,IervasiG,KuttyS,KoestenbergerM.

    Nomograms of pulsed Doppler velocities, times, and velocity time integrals for semilunar valves and great arteries in healthyCaucasian children. Int J Cardiol. 2019 Jun 15;285:133-139. doi: 10.1016/j.ijcard.2019.03.001. Epub 2019 Mar 3. No abstractavailable.

    194 Jalil B,HartwigV,MoroniD, Salvetti O, Benassi A, Jalil Z, Pistoia L,Minutoli Tegrimi T, Quinones-GalvanA,Iervasi G, L'AbbateA,

    GuiducciL.APilotStudyofInfraredThermographyBasedAssessmentofLocalSkinTemperatureResponseinOverweightandLeanWomenduringOralGlucoseToleranceTest.JClinMed.2019Feb19;8(2).pii:E260.doi:10.3390/jcm8020260.

    195 FusaroM,GallieniM,AghiA,RizzoMA,IervasiG,NickolasTL,FabrisF,MereuMC,GianniniS,SellaS,GiustiA,PitinoA,D'ArrigoG,

    RossiniM,GattiD,RaveraM,DiLulloL,BellasiA,BrunoriG,PiccoliA,TripepiG,PlebaniM.Osteocalcin(boneGLAprotein)levels,vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus. J Nephrol. 2019Aug;32(4):635-643.doi:10.1007/s40620-019-00595-1.Epub2019Feb13.

    196 PingitoreA,MastorciF,PiaggiP,AquaroGD,MolinaroS,RavaniM,DeCaterinaA,TrianniG,NdreuR,BertiS,VassalleC,IervasiG.

    UsefulnessofTriiodothyronineReplacementTherapyinPatientsWithSTElevationMyocardialInfarctionandBorderline/ReducedTriiodothyronineLevels(fromtheTHIRSTStudy).AmJCardiol.2019Mar15;123(6):905-912.doi:10.1016/j.amjcard.2018.12.020.Epub2018Dec18.

    197 Voges I, Giordano R, Koestenberg M, Marchese P, Scalese M, Ait-Ali L, Santoro G,Iervasi G, Valverde I, Kutty S, Cantinotti M.

    Nomograms for Cardiovascular Magnetic Resonance Measurements in the Pediatric Age Group: To Define the Normal and theExpected Abnormal Values in Corrected/Palliated Congenital Heart Disease: A Systematic Review. J Magn Reson Imaging. 2019May;49(5):1222-1235.doi:10.1002/jmri.26614.Epub2019Jan7.Review.

    198 Bunevicius, A., Laws, E.R., Saudargiene, A., Tamasauskas, A., Iervasi, G., Deltuva, V., Smith, T.R., Bunevicius, R. Common genetic

    variationsofdeiodinasegenesandprognosisofbraintumorpatients.Endocrine.Volume66,Issue3,1December2019,Pages563-572

    199 Ravera,M.,Nickolas,T.,Plebani,M., Iervasi,G.,Aghi,A.,Khairallah,P.,Gallieni,M.,Mereu,M.C.,Giannini,S.,Sella,S.,Zaninotto,M.,

    Paoletti,E.,Bussalino,E.,DiLullo,L.,Bellasi,A.,Cosmai,L.,Foramitti,M.,Malberti,F.,Brandi,M.L.,Ferrari,S.,Tripepi,G.,Fusaro,M.Overweight-obesity is associated with decreased vitamin K2 levels in hemodialysis patients. Clinical Chemistry and LaboratoryMedicine2020

    200 Cappellani, D., Papini, P., Pingitore, A., Tomisti, L.,Mantuano,M., Di Certo, A.M.,Manetti, L.,Marconcini, G., Scattina, I., Urbani, C.,

    Morganti,R.,Marcocci,C.,Materazzi,G.,Iervasi,G.,Martino,E.,Bartalena,L.,Bogazzi,F.ComparisonBetweenTotalThyroidectomyandMedical Therapy for Amiodarone-Induced Thyrotoxicosis. The Journal of clinical endocrinology andmetabolismVolume 105,Issue1,1January2020

    201 Gorini,F.,Bustaffa,E.,Coi,A.,Iervasi,G.,Bianchi,F.Bisphenolsasenvironmentaltriggersofthyroiddysfunction:Cluesandevidence.

    InternationalJournalofEnvironmentalResearchandPublicHealth,2020,17(8),2654.202 Cantinotti, M., Scalese, M., Giordano, R., Franchi, E., Marchese, P., Vicava, C., Assanta, N., Iervasi, G., Kutty, S., Koestenberger, M.

    Pediatricnomogramsforleftventriclebiplane2DvolumesinhealthyCaucasianchildren.Echocardiography.Volume37,Issue6,1June2020,Pages971-975

    203 Cantinotti,M.,Koestenberger,M.,Santoro,G.,Assanta,N.,Franchi,E.,Paterni,M.,Iervasi,G.,D'Andrea,A.,D'Ascenzi,F.,Giordano,R.,

    Galderisi,M.Normalbasic2Dechocardiographicvaluestoscreenandfollowuptheathlete'sheartfromjuniorstoadults:Whatisknownandwhatismissing.Acriticalreview.EuropeanJournalofPreventiveCardiology.Volume27,Issue12,1August2020,Pages1294-1306

    204 Fusaro,M.,Cosmai,L.,Evenepoel,P.,Nickolas,T.L.,Cheung,A.M.,Aghi,A.,Tripepi,G.,Plebani,M.,Iervasi,G.,Vettor,R.,Zaninotto,M.,

    Ravera,M.,Foramitti,M.,Giannini,S.,Sella,S.,Gallieni,M.VitaminKandkidneytransplantation.Nutrients.OpenAccessVolume12,Issue9,September2020,Articlenumber2717,Pages1-13.

    205 Forini,F.,Nicolini,G.,Kusmic,C.,D'Aurizio,R.,Mercatanti,A.,Iervasi,G.,Pitto,L.T3CriticallyAffectstheMhrt/Brg1AxistoRegulate

    theCardiacMHCSwitch:RoleofanEpigeneticCross-Talk.Cells.Volume9,Issue10,24September2020206 Forini,F.,Canale,P.,Nicolini,G.,Iervasi,G.Mitochondria-targeteddrugdeliveryincardiovasculardisease:Alongroadtonano-cardio

    medicine.Pharmaceutics,2020,12(11),pp.1-24,1122207 Sabatino,L.,Kusmic,C., Iervasi,G.Modificationofcardiacthyroidhormonedeiodinasesexpressioninan ischemia/reperfusionrat

    modelafterT3infusion.MolecularandCellularBiochemistry,2020,475(1-2),pp.205-214. CHAPTERSINBOOK1. CarpiA,IervasiG,NicoliniA,BianchiR,UrbanoU,DiCoscioG.COneyearexperiencewithaspirationofthyroidnodules.In“Advances

    inthyroidneoplasia”,AndreoliM.,RobbinsJ.,MonacoE.,Eds,FieldEducationalItalia,Roma,1981,pp.293-300

  • Page 16 - Curriculum vitae of Giorgio Iervasi [email protected]

    2. BianchiR, IervasiG “ LaTiroide” in “Semeiologia eDiagnostica funzionale”, PaseroG,GiordaniR,Eds, CasaEditriceAmbrosiana,

    Milano1985,pp.562-5733. Bianchi R, Iervasi G, Molea N, Cazzuola F, Ferdeghini M, Pilo A Kinetic studies of thyroid hormones in familial disalbuminemic

    hyperthyroxinemia(FDH)andincongenitalTBGelevation(HTBG).PlenumPress,NewYork,1986,pp.499-5034. Iervasi G, Boni G, FerdeghiniM “I Dosaggi Radioimmunologici” in “Immunologia inMedicina” Dammacco F Ed, Casa Editrice Edi

    Ermes,Milano1989,pp.1618-16305. IervasiG,BertiS,VitekF,BiaginiA,ClericoA,PiloA,TurchiS,BarattoMT,CazzuolaF,BianchiRKineticsof theatrialnatriuretic

    peptideinhumansbyanewtracermethod.In“Radioactiveisotopesinclinicalmedicineandresearch”.F.K.Schattauered.SpringerVerlag,Stuttgart,NewYork1992,pp.322-5

    6. Berti S, Palmieri C, BoniniR, RavaniM, ClericoA, Iervasi G, Gazzetti P, Pugliese S, BiaginiAAcuteEnoximone effect on systemic

    hemodynamicrenal functionandhormonalactivation inpatientswithheart failure. In“MechanismandTherapyofHeartFailure”eds.P.K.Singal,R.E.BeamishandN.S.Dhalla,Boston,KluwerAcademicPublishers,1994

    7. IervasiG, ClericoA, Berti S, PiloA, Vitek F,Manfredi C, IasconeMR,Maffei S, BiaginiAPeripheral resistance to atrial natriuretic

    peptide in patients with idiopathic dilated cardiomyopathy. In “Mechanism and Therapy of Heart Failure” eds. P.K. Singal, R.E.BeamishandN.S.Dhalla,Boston,KluwerAcademicPublishers,1994

    8. VitekF,PiloA,IervasiG,ClericoA,BertiS,IasconeMR,ManfrediC,BiaginiA,BianchiR,DonatoLCirculatorymodelforinvivokinetic

    studiesofatrialnatriureticpeptide(ANP) inhumans.Computers inCardiology,BethesdaSeptember25-28,1994, IEEEComputerSocietyPress,LosAlamos1994,pp.385-8

    9. IervasiG,EmdinMControlloneuroendocrinodelsistemacardiovascolare. In“TrattatodiCardiologiaANMCO”,ExcerptaMedica–

    ESIStampaMedica,Milano2000pp.133-148.10. EmdinM.,IervasiG.Scompensocardiacoesistemaneuroendocrino.IQuadernidelCNR,2001,PrimulaMultimediaS.r.L11. IervasiG,ZucchelliGC.Diagnosticabiochimicadellemalattietiroidee.In“Trattatoitalianodimedicinadilaboratorio.CasaEditrice

    Piccin,Vol.VII,Capitolo15,2008pp.421–44812. Iervasi G, Pingitore A. Heart failure, Iodine intake and thyroid hormones. In “ Comprehensive handbook on iodine: nutritional,

    endocrineandpathologicalaspects.V.Preedy,G.N.Burrow,R.R.WatsonEds.,ElsevierInc.,OxfordAcademicPress2009:pp1073-1086

    13. IervasiG,FommeiE.HypertensionandHypothyroidism,athyroiddysfunctionfrequentlyassociatedwithaabnormaldietaryiodine

    intake.In“Comprehensivehandbookoniodine:nutritional,endocrineandpathologicalaspects.V.Preedy,G.N.Burrow,R.R.WatsonEds.,ElsevierInc.,OxfordAcademicPress2009:pp1057-1071

    14. IervasiG.,SabatinoL.,NicoliniG.Lowtriiodothyroninesyndromeasapowerfulpredictorofdeathinheartfailure.In:“Thyroidand

    heartfailure:frompathophysiologytoclinics”.G.Iervasi,A.PingitoreEds,Springer–VerlagItalia2009:pp.179-190.15. PingitoreA. ,IervasiG.Thyroidhormone inheart failure:potential therapeutic implications. In“Frontieres inCardiovascularDrug

    Discovery”,A.Rahman,MIChoudharyEds,BenthamSciencePublishers2010,Vol1pp16. Bottoni A., Lorenzoni G., Iervasi G. Tecniche diagnostiche per lo studio della tiroide. In “Fondamenti di medicina nucleare”. D.

    Volterrani,P.A.Erba,G.MarianiEds.Springer–VerlagItalia2010.pp617-650.TheundersignedauthorizestoprocessherpersonaldataforthepurposeshereininaccordancewiththetermsintheLegislativeDecreeNo196of30/06/2003

    Pisa,30/11/2020

    GiorgioIervasi

    2020-12-10T14:15:43+0100Iervasi Giorgio